Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
22.01
+2.58 (13.28%)
At close: Nov 20, 2025, 4:00 PM EST
22.07
+0.06 (0.27%)
After-hours: Nov 20, 2025, 7:59 PM EST

Olema Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
1,511430766983721,840
Upgrade
Market Cap Growth
122.66%-43.88%679.84%-73.58%-79.78%-
Upgrade
Enterprise Value
1,187217492-122661,861
Upgrade
Last Close Price
22.015.8314.032.459.3648.08
Upgrade
PB Ratio
4.911.053.020.501.315.44
Upgrade
P/TBV Ratio
4.911.053.020.501.315.44
Upgrade
Debt / Equity Ratio
0.020.000.010.010.01-
Upgrade
Quick Ratio
7.9710.4512.1412.3731.8673.84
Upgrade
Current Ratio
8.0310.5012.3312.6232.2374.62
Upgrade
Return on Equity (ROE)
-59.23%-39.06%-42.82%-43.47%-22.83%-13.13%
Upgrade
Return on Assets (ROA)
-34.41%-24.43%-26.63%-26.14%-13.99%-7.85%
Upgrade
Return on Capital (ROIC)
-39.11%-26.67%-28.74%-27.41%-14.27%-7.99%
Upgrade
Return on Capital Employed (ROCE)
-51.60%-34.80%-41.10%-53.70%-24.90%-6.40%
Upgrade
Earnings Yield
-9.92%-30.11%-12.61%-106.63%-19.11%-1.20%
Upgrade
FCF Yield
-8.91%-24.30%-10.93%-83.88%-14.05%-1.08%
Upgrade
Buyback Yield / Dilution
-54.75%-29.83%-13.13%-1.19%-462.91%-170.75%
Upgrade
Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q